Successful Treatment of Multiple Multidrug Resistant Intracranial Tuberculomata.
Richard P SullivanHazel F GoldbergRoss S MellickJeffrey J PostPublished in: Case reports in infectious diseases (2016)
A 21-year-old Bangladesh-born man presented with a month history of evolving neurological symptoms in the context of a six-month history of fever, night sweats, and axillary lymphadenopathy. He was subsequently diagnosed with multiple multidrug resistant intracranial tuberculomata and was successfully treated over two years. Intracranial multidrug resistant tuberculosis has a high mortality and successful treatment is rarely reported. Management is complex and requires consideration of the penetration and likely effect of antituberculous agents within the central nervous system. We discuss the role of various antituberculous agents, the duration of therapy, the utility of corticosteroids, the value of intrathecal and systemic therapy, and the need for rapid diagnosis.
Keyphrases
- multidrug resistant
- drug resistant
- gram negative
- acinetobacter baumannii
- klebsiella pneumoniae
- optic nerve
- lymph node
- mycobacterium tuberculosis
- stem cells
- sleep quality
- cardiovascular events
- type diabetes
- neoadjuvant chemotherapy
- emergency department
- cardiovascular disease
- risk factors
- escherichia coli
- sentinel lymph node
- cystic fibrosis
- physical activity
- early stage
- gestational age
- pseudomonas aeruginosa
- brain injury
- cerebral ischemia
- hiv infected
- antiretroviral therapy
- adverse drug